Juan-Manuel Anaya, MD, PhD. National Academy of Medicine of Colombia. At the University of Rosario, in Bogota, Colombia, he founded the Center for Autoimmune Diseases Research (CREA), where he was its Director and created the Translational Medicine Chair. Coordinator of Science of Life and Health Group during Colombia's "Mission of Wise Men and Women." His research is focused on the search and discovery of common mechanisms of autoimmune diseases (that is, the autoimmune tautology theory).

Luis Andrade is Professor of Rheumatology, at the Federal University of Sao Paulo in Brazil. He received his M.D. degree from Federal University of Minas Gerais and his Ph.D. degree in Rheumatology from Escola Paulista de Medicina, in Brazil. Post-doctoral training in molecular and cellular biology of autoantibodies at the Scripps Research Institute in the USA under supervision of Professor Eng Tan. Luis Andrade is the Chair of IUIS Quality and Assessment Committee (https://iuis.org/committees/qas/members/) since 2017, and Co-coordinator of ICAP (International Consensus on ANA Patterns) since 2014. He is a former Chair and current member of the Autoantibody Standardizing Subcommittee (www.autoab.org) affiliated with the IUIS. He is member of the American College of Rheumatology, the Brazilian Society of Rheumatology and the Brazilian Society of Clinical Pathology and Laboratory Medicine. He serves in the editorial board of a variety of journals in the area of autoimmunity and rheumatology. His research interests focus on the autoantibodies, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, capillaroscopy, and molecular biology of autoantigens and autoimmune rheumatic diseases. More recently, he concentrates on the fields of autoantibody testing and standardization as well as the interface between autoimmunity and immunodeficiency.

Martin Aringer, M.D., is Professor of Medicine, chief of the division of Rheumatology and director of the interdisciplinary University Center of Autoimmune and Rheumatic Entities (UCARE) of the University Medical Centre and Faculty of Medicine at the TU Dresden, Dresden, Germany. From 2003 to 2006 he was an Associate Professor of Medicine at Vienna Medical University, where he also received his Internal Medicine and Rheumatology training under Prof. Josef Smolen. From 1997 to 1999, Dr. Aringer joined the laboratory of Dr. John O’Shea at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, in Bethesda, MD, as a recipient of a Max Kade Postdoctoral Research. His main scientific focus are SLE and systemic sclerosis.